Free Trial

Calavo Growers (CVGW) Financials

Calavo Growers logo
$26.52 +0.94 (+3.67%)
Closing price 05/27/2025 04:00 PM Eastern
Extended Trading
$26.41 -0.11 (-0.41%)
As of 05/27/2025 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.
Annual Income Statements for Calavo Growers

Annual Income Statements for Calavo Growers

This table shows Calavo Growers' income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2024 2023 2022
Period end date 10/31/2024 10/31/2023 10/31/2022
Net Income / (Loss) Attributable to Common Shareholders
-1.08 -8.34 -6.25
Consolidated Net Income / (Loss)
-1.02 -7.97 -6.60
Net Income / (Loss) Continuing Operations
6.85 5.05 -6.85
Total Pre-Tax Income
9.65 12 -3.12
Total Operating Income
17 12 6.79
Total Gross Profit
68 63 55
Total Revenue
662 594 770
Operating Revenue
662 594 770
Total Cost of Revenue
594 531 715
Operating Cost of Revenue
594 531 715
Total Operating Expenses
51 50 48
Selling, General & Admin Expense
50 47 47
Other Special Charges / (Income)
1.04 3.13 1.42
Total Other Income / (Expense), net
-7.07 -0.13 -9.91
Interest Expense
2.89 2.37 1.63
Interest & Investment Income
1.02 0.61 0.50
Other Income / (Expense), net
-5.20 1.64 -8.78
Income Tax Expense
2.33 6.15 3.17
Other Gains / (Losses), net
-0.48 -0.88 -0.56
Net Income / (Loss) Discontinued Operations
-7.87 -13 0.25
Net Income / (Loss) Attributable to Noncontrolling Interest
0.05 0.38 -0.35
Basic Earnings per Share
($0.06) ($0.47) ($0.35)
Weighted Average Basic Shares Outstanding
17.80M 17.75M 17.66M
Diluted Earnings per Share
($0.06) ($0.47) ($0.35)
Weighted Average Diluted Shares Outstanding
17.86M 17.85M 17.75M
Weighted Average Basic & Diluted Shares Outstanding
17.84M 17.80M 17.73M

Quarterly Income Statements for Calavo Growers

This table shows Calavo Growers' income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022
Period end date 1/31/2025 10/31/2024 7/31/2024 4/30/2024 1/31/2024 10/31/2023 7/31/2023 4/30/2023 1/31/2023 10/31/2022 7/31/2022
Net Income / (Loss) Attributable to Common Shareholders
4.42 -0.14 -0.73 6.06 -6.27 -7.91 6.63 -4.00 -3.07 -3.32 1.30
Consolidated Net Income / (Loss)
4.44 -0.10 -0.76 6.10 -6.26 -7.92 6.71 -3.96 -2.80 -3.48 1.32
Net Income / (Loss) Continuing Operations
4.44 -2.45 5.37 6.51 -2.57 -4.69 8.74 1.45 -0.45 -3.73 1.32
Total Pre-Tax Income
4.83 0.46 4.50 6.69 -2.00 -0.91 12 1.99 -0.64 -0.45 2.57
Total Operating Income
5.05 1.61 9.36 7.14 -3.09 0.68 10 1.92 -0.61 3.82 1.55
Total Gross Profit
16 15 20 20 11 12 22 16 13 1.26 19
Total Revenue
154 170 180 184 128 142 161 158 133 -178 342
Operating Revenue
154 170 180 184 128 142 161 158 133 -178 342
Total Cost of Revenue
139 155 160 164 117 130 139 143 120 -179 323
Operating Cost of Revenue
139 155 160 164 117 130 139 143 120 -179 323
Total Operating Expenses
11 13 11 13 14 11 12 14 14 -2.56 17
Selling, General & Admin Expense
10 13 11 13 13 9.28 13 13 12 -1.96 17
Other Special Charges / (Income)
0.40 - - 0.20 0.38 1.90 -1.20 0.39 2.05 0.27 0.30
Total Other Income / (Expense), net
-0.22 -1.15 -4.86 -0.44 1.08 -1.58 1.43 0.06 -0.04 -4.26 1.02
Interest Expense
0.21 0.27 0.83 0.96 0.82 0.98 0.77 0.24 0.38 0.36 0.49
Interest & Investment Income
0.85 - - - 0.00 - - - - - -
Other Income / (Expense), net
-0.85 -1.90 -4.02 0.52 1.91 -1.21 2.20 0.31 0.34 -4.41 1.50
Income Tax Expense
1.26 2.80 -1.44 0.39 0.57 3.30 2.41 0.48 -0.04 3.53 0.98
Other Gains / (Losses), net
0.86 -0.10 -0.58 0.20 0.00 -0.48 -0.50 -0.06 0.16 0.25 -0.27
Net Income / (Loss) Discontinued Operations
0.00 2.35 -6.13 -0.41 -3.68 -3.23 -2.03 -5.41 -2.35 - -
Net Income / (Loss) Attributable to Noncontrolling Interest
0.02 0.04 -0.03 0.04 0.01 -0.01 0.08 0.04 0.27 -0.17 0.02
Basic Earnings per Share
$0.25 ($0.01) ($0.04) $0.34 ($0.35) ($0.44) $0.37 ($0.23) ($0.17) ($0.18) $0.07
Weighted Average Basic Shares Outstanding
17.84M 17.80M 17.80M 17.80M 17.80M 17.75M 17.76M 17.72M 17.67M 17.66M 17.67M
Diluted Earnings per Share
$0.25 ($0.01) ($0.04) $0.34 ($0.35) ($0.44) $0.37 ($0.23) ($0.17) ($0.18) $0.07
Weighted Average Diluted Shares Outstanding
17.90M 17.86M 17.84M 17.87M 17.80M 17.85M 17.86M 17.88M 17.67M 17.75M 17.77M
Weighted Average Basic & Diluted Shares Outstanding
17.84M 17.84M 17.80M 17.80M 17.80M 17.80M 17.76M 17.78M 17.74M 17.73M 17.73M
Cash Dividends to Common per Share
$0.10 - $0.10 $0.10 $0.10 - $0.10 $0.10 $0.29 - -

Annual Cash Flow Statements for Calavo Growers

This table details how cash moves in and out of Calavo Growers' business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2024 2023 2022
Period end date 10/31/2024 10/31/2023 10/31/2022
Net Change in Cash & Equivalents
54 -0.28 0.28
Net Cash From Operating Activities
24 -14 50
Net Cash From Continuing Operating Activities
24 -14 50
Net Income / (Loss) Continuing Operations
-1.02 -7.97 -6.60
Consolidated Net Income / (Loss)
-1.02 -7.97 -6.60
Depreciation Expense
11 17 17
Amortization Expense
0.29 0.00 0.00
Non-Cash Adjustments To Reconcile Net Income
14 2.29 5.13
Changes in Operating Assets and Liabilities, net
0.27 -26 35
Net Cash From Investing Activities
80 -11 8.68
Net Cash From Continuing Investing Activities
80 -11 8.68
Purchase of Property, Plant & Equipment
-2.89 -11 -9.77
Divestitures
83 0.00 0.00
Sale and/or Maturity of Investments
0.00 0.00 18
Net Cash From Financing Activities
-50 25 -59
Net Cash From Continuing Financing Activities
-50 25 -59
Repayment of Debt
-126 -226 -306
Payment of Dividends
-8.92 -10 -20
Issuance of Debt
85 261 267
Other Financing Activities, net
-0.67 0.05 0.19
Cash Interest Paid
2.64 2.49 1.48
Cash Income Taxes Paid
2.29 1.49 2.60

Quarterly Cash Flow Statements for Calavo Growers

This table details how cash moves in and out of Calavo Growers' business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022
Period end date 1/31/2025 10/31/2024 7/31/2024 4/30/2024 1/31/2024 10/31/2023 7/31/2023 4/30/2023 1/31/2023 10/31/2022 7/31/2022
Net Change in Cash & Equivalents
-8.54 56 -3.15 -1.39 2.81 0.69 -2.04 2.40 -1.34 -0.33 0.20
Net Cash From Operating Activities
-4.43 11 11 2.09 0.06 4.73 -15 2.10 -5.88 8.05 21
Net Cash From Continuing Operating Activities
-4.43 11 11 2.09 0.06 4.73 -15 2.10 -5.88 8.05 21
Net Income / (Loss) Continuing Operations
4.44 -0.10 -0.76 6.10 -6.26 -7.92 6.71 -3.96 -2.80 -3.48 1.32
Consolidated Net Income / (Loss)
4.44 -0.10 -0.76 6.10 -6.26 -7.92 6.71 -3.96 -2.80 -3.48 1.32
Depreciation Expense
1.94 1.93 2.04 2.08 4.56 4.47 4.36 4.29 4.17 4.12 4.07
Non-Cash Adjustments To Reconcile Net Income
0.64 -9.57 -3.57 18 9.63 -4.47 -5.25 11 1.07 -12 -20
Changes in Operating Assets and Liabilities, net
-11 18 14 -24 -7.87 13 -21 -9.16 -8.32 19 36
Net Cash From Investing Activities
-0.28 83 -0.14 -1.35 -1.03 -0.60 -1.63 -3.28 -5.19 16 -3.95
Net Cash From Continuing Investing Activities
-0.28 83 -0.14 -1.35 -1.03 -0.60 -1.63 -3.28 -5.19 16 -3.95
Purchase of Property, Plant & Equipment
-0.28 -0.37 -0.14 -1.35 -1.03 -0.60 -1.63 -3.28 -5.19 -2.03 -3.95
Net Cash From Financing Activities
-3.83 -38 -14 -2.13 3.78 -3.44 15 3.58 9.72 -25 -17
Net Cash From Continuing Financing Activities
-3.83 -38 -14 -2.13 3.78 -3.44 15 3.58 9.72 -25 -17
Repayment of Debt
-0.33 -23 -25 -54 -23 -43 -72 -61 -50 -71 -69
Payment of Dividends
-3.57 -3.58 -1.78 -1.78 -1.78 -1.78 -1.78 -1.77 -5.10 - -
Issuance of Debt
0.11 -10 13 54 29 42 88 66 65 46 53
Other Financing Activities, net
-0.05 -0.04 - -0.03 -0.60 - - - 0.05 0.24 -

Annual Balance Sheets for Calavo Growers

This table presents Calavo Growers' assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2024 2023 2022
Period end date 10/31/2024 10/31/2023 10/31/2022
Total Assets
301 387 386
Total Current Assets
159 133 126
Cash & Equivalents
57 2.09 2.06
Accounts Receivable
42 34 59
Inventories, net
49 46 51
Prepaid Expenses
9.98 12 8.87
Current Deferred & Refundable Income Taxes
0.94 1.09 3.40
Plant, Property, & Equipment, net
54 61 0.00
Total Noncurrent Assets
88 193 260
Long-Term Investments
2.42 2.90 3.78
Goodwill
10 10 29
Noncurrent Deferred & Refundable Income Taxes
7.47 3.01 5.43
Other Noncurrent Operating Assets
68 71 215
Total Liabilities & Shareholders' Equity
301 387 386
Total Liabilities
99 177 162
Total Current Liabilities
73 82 102
Accounts Payable
8.74 5.10 10
Accrued Expenses
28 16 52
Current Deferred & Payable Income Tax Liabilities
2.77 0.00 -
Other Current Liabilities
34 30 40
Total Noncurrent Liabilities
26 95 60
Other Noncurrent Operating Liabilities
26 26 59
Commitments & Contingencies
0.00 0.00 0.00
Total Equity & Noncontrolling Interests
202 210 223
Total Preferred & Common Equity
200 209 222
Total Common Equity
200 209 222
Common Stock
178 176 171
Retained Earnings
22 32 51
Noncontrolling Interest
1.44 1.39 1.02

Quarterly Balance Sheets for Calavo Growers

This table presents Calavo Growers' assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q1 2025 Q3 2024 Q2 2024 Q1 2024 Q3 2023 Q2 2023 Q1 2023 Q3 2022
Period end date 1/31/2025 7/31/2024 4/30/2024 1/31/2024 7/31/2023 4/30/2023 1/31/2023 7/31/2022
Total Assets
299 382 411 395 415 407 396 431
Total Current Assets
158 238 262 246 150 145 133 148
Cash & Equivalents
48 1.13 4.27 5.66 1.40 4.20 1.80 2.51
Accounts Receivable
47 52 56 35 76 69 62 78
Inventories, net
50 45 53 53 55 56 54 49
Prepaid Expenses
12 8.86 8.19 10 13 11 11 9.22
Current Deferred & Refundable Income Taxes
0.94 3.61 2.06 0.89 4.15 4.33 4.12 8.50
Plant, Property, & Equipment, net
53 56 58 59 114 0.00 116 114
Total Noncurrent Assets
88 88 91 90 150 262 148 168
Long-Term Investments
3.29 2.53 3.11 2.90 3.38 3.88 3.94 25
Goodwill
10 10 10 10 29 29 29 29
Noncurrent Deferred & Refundable Income Taxes
7.47 3.01 3.01 3.01 5.78 5.59 5.43 5.32
Other Noncurrent Operating Assets
67 72 75 73 106 218 103 101
Total Liabilities & Shareholders' Equity
299 382 411 395 415 407 396 431
Total Liabilities
96 177 204 192 196 194 180 205
Total Current Liabilities
71 117 133 121 101 116 105 118
Accounts Payable
6.73 9.82 6.51 4.92 16 19 17 12
Accrued Expenses
30 17 20 21 42 50 52 52
Current Deferred & Payable Income Tax Liabilities
4.12 - - - - - - -
Other Current Liabilities
30 42 53 37 42 45 34 54
Total Noncurrent Liabilities
25 61 71 71 95 78 75 86
Other Noncurrent Operating Liabilities
25 27 25 26 55 51 53 56
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
203 205 207 203 219 213 217 226
Total Preferred & Common Equity
201 204 206 201 218 212 215 225
Total Common Equity
201 204 206 201 218 212 215 225
Common Stock
178 178 177 177 176 175 173 170
Retained Earnings
23 26 29 24 42 37 43 54
Noncontrolling Interest
1.46 1.41 1.44 1.40 1.41 1.32 1.29 1.18

Annual Metrics And Ratios for Calavo Growers

This table displays calculated financial ratios and metrics derived from Calavo Growers' official financial filings.

Metric 2024 2023 2022
Period end date 10/31/2024 10/31/2023 10/31/2022
Growth Metrics
- - -
Revenue Growth
11.35% -22.81% -27.10%
EBITDA Growth
-28.00% 113.19% -21.41%
EBIT Growth
-16.77% 796.48% -297.42%
NOPAT Growth
111.75% 26.18% -97.47%
Net Income Growth
87.15% -20.68% 44.62%
EPS Growth
87.23% -34.29% 47.76%
Operating Cash Flow Growth
268.80% -128.80% 270.12%
Free Cash Flow Firm Growth
-52.72% 42.20% -77.59%
Invested Capital Growth
-10.94% -26.58% -15.57%
Revenue Q/Q Growth
-34.61% -14.58% -36.96%
EBITDA Q/Q Growth
97.92% 0.08% 485.25%
EBIT Q/Q Growth
733.88% -2.30% 90.49%
NOPAT Q/Q Growth
352.12% -17.20% 148.80%
Net Income Q/Q Growth
88.42% -125.69% 59.14%
EPS Q/Q Growth
87.76% -123.81% 61.11%
Operating Cash Flow Q/Q Growth
33.33% -29.75% 15.85%
Free Cash Flow Firm Q/Q Growth
-70.55% 463.65% 59.77%
Invested Capital Q/Q Growth
-7.64% -37.03% -4.95%
Profitability Metrics
- - -
Gross Margin
10.25% 10.54% 7.11%
EBITDA Margin
3.39% 5.24% 1.90%
Operating Margin
2.53% 2.05% 0.88%
EBIT Margin
1.74% 2.33% -0.26%
Profit (Net Income) Margin
-0.15% -1.34% -0.86%
Tax Burden Percent
-10.61% -65.95% 211.67%
Interest Burden Percent
83.75% 87.25% 156.89%
Effective Tax Rate
24.09% 50.89% 0.00%
Return on Invested Capital (ROIC)
8.40% 3.18% 2.00%
ROIC Less NNEP Spread (ROIC-NNEP)
33.37% 52.92% -88.11%
Return on Net Nonoperating Assets (RNNOA)
-8.90% -6.85% -4.93%
Return on Equity (ROE)
-0.50% -3.67% -2.93%
Cash Return on Invested Capital (CROIC)
19.98% 33.83% 18.88%
Operating Return on Assets (OROA)
3.35% 3.58% -0.48%
Return on Assets (ROA)
-0.30% -2.06% -1.59%
Return on Common Equity (ROCE)
-0.49% -3.65% -2.92%
Return on Equity Simple (ROE_SIMPLE)
-0.51% -3.81% -2.97%
Net Operating Profit after Tax (NOPAT)
13 5.99 4.75
NOPAT Margin
1.92% 1.01% 0.62%
Net Nonoperating Expense Percent (NNEP)
-24.97% -49.74% 90.11%
Return On Investment Capital (ROIC_SIMPLE)
6.29% 2.40% 2.12%
Cost of Revenue to Revenue
89.75% 89.46% 92.89%
SG&A Expenses to Revenue
7.56% 7.96% 6.05%
R&D to Revenue
0.00% 0.00% 0.00%
Operating Expenses to Revenue
7.72% 8.48% 6.23%
Earnings before Interest and Taxes (EBIT)
12 14 -1.99
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
22 31 15
Valuation Ratios
- - -
Price to Book Value (P/BV)
2.34 2.10 2.63
Price to Tangible Book Value (P/TBV)
2.47 2.21 3.14
Price to Revenue (P/Rev)
0.71 0.74 0.76
Price to Earnings (P/E)
0.00 0.00 0.00
Dividend Yield
1.90% 2.38% 3.48%
Earnings Yield
0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)
2.89 2.96 2.67
Enterprise Value to Revenue (EV/Rev)
0.62 0.80 0.75
Enterprise Value to EBITDA (EV/EBITDA)
18.35 15.19 39.78
Enterprise Value to EBIT (EV/EBIT)
35.68 34.14 0.00
Enterprise Value to NOPAT (EV/NOPAT)
32.39 78.85 122.27
Enterprise Value to Operating Cash Flow (EV/OCF)
16.84 0.00 11.56
Enterprise Value to Free Cash Flow (EV/FCFF)
13.62 7.40 12.94
Leverage & Solvency
- - -
Debt to Equity
0.00 0.19 0.01
Long-Term Debt to Equity
0.00 0.18 0.01
Financial Leverage
-0.27 -0.13 0.06
Leverage Ratio
1.67 1.78 1.85
Compound Leverage Factor
1.40 1.55 2.90
Debt to Total Capital
0.00% 15.68% 0.53%
Short-Term Debt to Total Capital
0.00% 0.26% 0.00%
Long-Term Debt to Total Capital
0.00% 15.42% 0.53%
Preferred Equity to Total Capital
0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.72% 0.56% 0.45%
Common Equity to Total Capital
99.28% 83.76% 99.01%
Debt to EBITDA
0.00 1.26 0.08
Net Debt to EBITDA
0.00 1.07 -0.39
Long-Term Debt to EBITDA
0.00 1.23 0.08
Debt to NOPAT
0.00 6.52 0.25
Net Debt to NOPAT
0.00 5.56 -1.20
Long-Term Debt to NOPAT
0.00 6.41 0.25
Altman Z-Score
5.60 3.42 4.40
Noncontrolling Interest Sharing Ratio
0.69% 0.56% 0.53%
Liquidity Ratios
- - -
Current Ratio
2.17 1.63 1.23
Quick Ratio
1.35 0.44 0.60
Cash Flow Metrics
- - -
Free Cash Flow to Firm (FCFF)
30 64 45
Operating Cash Flow to CapEx
844.95% -135.27% 514.21%
Free Cash Flow to Firm to Interest Expense
10.43 26.92 27.52
Operating Cash Flow to Interest Expense
8.44 -6.10 30.80
Operating Cash Flow Less CapEx to Interest Expense
7.44 -10.61 24.81
Efficiency Ratios
- - -
Asset Turnover
1.92 1.54 1.85
Accounts Receivable Turnover
17.45 12.79 11.16
Inventory Turnover
12.50 10.90 14.49
Fixed Asset Turnover
11.49 0.00 0.00
Accounts Payable Turnover
85.81 68.43 70.68
Days Sales Outstanding (DSO)
20.91 28.54 32.69
Days Inventory Outstanding (DIO)
29.20 33.48 25.20
Days Payable Outstanding (DPO)
4.25 5.33 5.16
Cash Conversion Cycle (CCC)
45.85 56.69 52.73
Capital & Investment Metrics
- - -
Invested Capital
142 160 218
Invested Capital Turnover
4.38 3.15 3.24
Increase / (Decrease) in Invested Capital
-17 -58 -40
Enterprise Value (EV)
411 473 581
Market Capitalization
469 438 586
Book Value per Share
$11.25 $11.76 $12.54
Tangible Book Value per Share
$10.68 $11.17 $10.52
Total Capital
202 249 225
Total Debt
0.00 39 1.20
Total Long-Term Debt
0.00 38 1.20
Net Debt
-59 33 -5.72
Capital Expenditures (CapEx)
2.89 11 9.77
Debt-free, Cash-free Net Working Capital (DFCFNWC)
28 49 21
Debt-free Net Working Capital (DFNWC)
85 52 24
Net Working Capital (NWC)
85 52 24
Net Nonoperating Expense (NNE)
14 14 11
Net Nonoperating Obligations (NNO)
-59 -50 -5.72
Total Depreciation and Amortization (D&A)
11 17 17
Debt-free, Cash-free Net Working Capital to Revenue
4.28% 8.32% 2.67%
Debt-free Net Working Capital to Revenue
12.91% 8.80% 3.08%
Net Working Capital to Revenue
12.91% 8.69% 3.08%
Earnings Adjustments
- - -
Adjusted Basic Earnings per Share
($0.06) ($0.47) ($0.35)
Adjusted Weighted Average Basic Shares Outstanding
17.80M 17.75M 17.66M
Adjusted Diluted Earnings per Share
($0.06) ($0.47) ($0.35)
Adjusted Weighted Average Diluted Shares Outstanding
17.86M 17.75M 17.66M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
17.84M 17.80M 17.73M
Normalized Net Operating Profit after Tax (NOPAT)
13 11 5.74
Normalized NOPAT Margin
2.04% 1.81% 0.75%
Pre Tax Income Margin
1.46% 2.03% -0.41%
Debt Service Ratios
- - -
EBIT to Interest Expense
3.98 5.84 -1.22
NOPAT to Interest Expense
4.39 2.53 2.91
EBIT Less CapEx to Interest Expense
2.98 1.33 -7.21
NOPAT Less CapEx to Interest Expense
3.39 -1.98 -3.08
Payout Ratios
- - -
Dividend Payout Ratio
-871.19% -130.95% -307.94%
Augmented Payout Ratio
-871.19% -130.95% -307.94%

Quarterly Metrics And Ratios for Calavo Growers

This table displays calculated financial ratios and metrics derived from Calavo Growers' official financial filings.

Metric Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022
Period end date 1/31/2025 10/31/2024 7/31/2024 4/30/2024 1/31/2024 10/31/2023 7/31/2023 4/30/2023 1/31/2023 10/31/2022 7/31/2022
Growth Metrics
- - - - - - - - - - -
Revenue Growth
20.99% 19.52% 11.65% 16.49% -3.88% 179.98% -52.96% -52.24% -51.56% -165.03% 19.99%
EBITDA Growth
81.76% -58.38% -56.01% 49.32% -13.43% 11.65% 135.48% 59.05% 2,771.92% 123.73% 52.37%
EBIT Growth
456.20% 45.37% -57.00% 243.12% -344.53% 10.34% 306.19% 44,520.00% 94.06% 96.98% 2,445.83%
NOPAT Growth
272.87% -1,844.43% 52.49% 361.69% -410.08% -82.28% 745.79% -52.82% 79.75% 122.60% 123.56%
Net Income Growth
170.88% 98.69% -111.36% 254.02% -123.86% -127.39% 409.34% -1,334.78% 32.81% 73.29% 110.20%
EPS Growth
171.43% 97.73% -110.81% 247.83% -105.88% -144.44% 428.57% -2,200.00% 26.09% 75.34% 109.46%
Operating Cash Flow Growth
-7,732.76% 128.99% 174.14% -0.29% 100.99% -41.21% -173.95% -88.93% -346.06% 584.44% 956.87%
Free Cash Flow Firm Growth
-88.32% -84.16% 771.09% 550.19% 244.69% 36.22% -143.04% -68.05% 224.56% 4,078.05% 2,585.70%
Invested Capital Growth
-3.27% -10.94% -39.28% -31.52% -33.28% -26.58% 10.83% -4.46% -8.73% -15.57% -14.18%
Revenue Q/Q Growth
-9.16% -5.37% -2.60% 44.49% -10.27% -11.60% 1.63% 19.22% -45.49% -151.99% 3.19%
EBITDA Q/Q Growth
274.50% -77.79% -24.20% 188.21% -14.25% -76.52% 157.30% 67.09% -0.33% -50.48% 73.79%
EBIT Q/Q Growth
1,551.90% -105.42% -30.29% 749.83% -122.68% -104.26% 456.21% 941.89% -30.54% -119.31% 61,000.00%
NOPAT Q/Q Growth
145.24% -166.82% 83.84% 796.58% -556.51% -94.16% 456.62% 443.65% -120.07% 178.82% -68.95%
Net Income Q/Q Growth
4,364.42% 86.35% -112.49% 197.47% 21.00% -218.07% 269.39% -41.68% 19.75% -364.46% 577.17%
EPS Q/Q Growth
2,600.00% 75.00% -111.76% 197.14% 20.45% -218.92% 260.87% -35.29% 5.56% -357.14% 800.00%
Operating Cash Flow Q/Q Growth
-140.85% -5.22% 446.51% 3,506.90% -98.77% 130.69% -834.99% 135.70% -173.00% -61.40% 10.07%
Free Cash Flow Firm Q/Q Growth
-4.21% -91.76% 39.29% 4.53% 29.89% 449.33% -234.95% -43.71% -47.99% 10.36% 0.18%
Invested Capital Q/Q Growth
6.16% -7.64% -3.77% 2.51% -2.26% -37.03% 8.53% -0.12% 7.56% -4.95% -6.44%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
10.19% 8.76% 11.19% 11.04% 8.43% 8.33% 13.68% 9.90% 9.86% 0.00% 5.41%
EBITDA Margin
3.98% 0.96% 4.11% 5.28% 2.65% 2.77% 10.43% 4.12% 2.94% 0.00% 2.08%
Operating Margin
3.27% 0.95% 5.21% 3.87% -2.42% 0.48% 6.35% 1.22% -0.46% 0.00% 0.45%
EBIT Margin
2.72% -0.17% 2.97% 4.15% -0.92% -0.37% 7.71% 1.41% -0.20% 0.00% 0.89%
Profit (Net Income) Margin
2.87% -0.06% -0.42% 3.31% -4.90% -5.57% 4.17% -2.50% -2.11% 0.00% 0.39%
Tax Burden Percent
91.86% -22.76% -16.92% 91.13% 312.54% 872.25% 57.61% -199.30% 435.36% 775.72% 51.25%
Interest Burden Percent
115.06% -158.13% 84.39% 87.43% 169.95% 171.64% 93.83% 89.06% 242.26% 76.10% 84.12%
Effective Tax Rate
25.99% 613.35% -32.00% 5.83% 0.00% 0.00% 20.68% 24.36% 0.00% 0.00% 38.29%
Return on Invested Capital (ROIC)
10.84% -21.27% 34.12% 18.37% -5.11% 1.05% 14.51% 3.37% -1.37% 0.00% 1.38%
ROIC Less NNEP Spread (ROIC-NNEP)
9.41% -36.11% 194.10% 23.04% 23.16% 30.95% 7.15% -22.64% -10.74% 0.00% 8.14%
Return on Net Nonoperating Assets (RNNOA)
-2.28% 9.63% -7.50% -1.45% -1.60% -4.01% 0.61% -2.16% -1.23% 0.00% 0.18%
Return on Equity (ROE)
8.56% -11.64% 26.62% 16.91% -6.71% -2.96% 15.12% 1.21% -2.60% 0.00% 1.56%
Cash Return on Invested Capital (CROIC)
16.55% 19.98% 50.25% 32.63% 41.76% 33.83% -7.27% 3.76% 1.55% 18.88% 11.33%
Operating Return on Assets (OROA)
5.39% -0.33% 7.54% 10.07% -1.37% -0.57% 12.69% 2.82% -0.48% 0.00% 2.45%
Return on Assets (ROA)
5.70% -0.12% -1.08% 8.02% -7.30% -8.57% 6.86% -5.01% -5.11% 0.00% 1.06%
Return on Common Equity (ROCE)
8.50% -11.56% 26.44% 16.80% -6.67% -2.94% 15.03% 1.20% -2.58% 0.00% 1.55%
Return on Equity Simple (ROE_SIMPLE)
4.80% 0.00% -4.34% -0.67% -5.68% 0.00% -1.62% -4.21% -2.43% 0.00% -7.19%
Net Operating Profit after Tax (NOPAT)
3.73 -8.25 12 6.72 -2.16 0.47 8.10 1.46 -0.42 2.67 0.96
NOPAT Margin
2.42% -4.86% 6.88% 3.64% -1.69% 0.33% 5.04% 0.92% -0.32% 0.00% 0.28%
Net Nonoperating Expense Percent (NNEP)
1.43% 14.84% -159.98% -4.67% -28.27% -29.90% 7.36% 26.01% 9.38% 48.84% -6.76%
Return On Investment Capital (ROIC_SIMPLE)
1.84% -4.09% - - -0.87% 0.19% - - - 1.19% -
Cost of Revenue to Revenue
89.81% 91.24% 88.81% 88.96% 91.57% 91.67% 86.32% 90.10% 90.14% 0.00% 94.59%
SG&A Expenses to Revenue
6.66% 7.68% 5.85% 7.06% 10.55% 6.53% 8.08% 8.44% 8.77% 0.00% 4.87%
R&D to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue
6.92% 7.81% 5.98% 7.17% 10.85% 7.86% 7.33% 8.69% 10.31% 0.00% 4.96%
Earnings before Interest and Taxes (EBIT)
4.20 -0.29 5.34 7.66 -1.18 -0.53 12 2.23 -0.27 -0.59 3.06
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
6.14 1.64 7.38 9.73 3.38 3.94 17 6.52 3.90 3.53 7.12
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
2.03 2.34 2.08 2.32 2.25 2.10 3.03 2.63 2.58 2.63 3.09
Price to Tangible Book Value (P/TBV)
2.14 2.47 2.19 2.44 2.37 2.21 3.61 3.15 3.09 3.14 3.68
Price to Revenue (P/Rev)
0.59 0.71 0.42 0.48 0.77 0.74 0.95 0.63 0.53 0.76 0.57
Price to Earnings (P/E)
42.50 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Dividend Yield
3.06% 1.90% 1.68% 1.49% 1.57% 2.38% 1.31% 1.24% 0.92% 3.48% 2.94%
Earnings Yield
2.35% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)
2.37 2.89 2.95 3.23 3.14 2.96 2.75 2.47 2.45 2.67 3.05
Enterprise Value to Revenue (EV/Rev)
0.52 0.62 0.45 0.52 0.83 0.80 1.00 0.66 0.55 0.75 0.57
Enterprise Value to EBITDA (EV/EBITDA)
14.38 18.35 40.16 24.98 16.05 15.19 22.40 26.96 30.16 39.78 0.00
Enterprise Value to EBIT (EV/EBIT)
21.19 35.68 0.00 98.47 37.98 34.14 49.16 120.07 221.50 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)
17.62 32.39 161.97 0.00 136.76 78.85 96.23 0.00 0.00 122.27 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)
17.96 16.84 24.83 0.00 0.00 0.00 0.00 23.03 13.68 11.56 16.09
Enterprise Value to Free Cash Flow (EV/FCFF)
14.08 13.62 4.44 8.05 6.03 7.40 0.00 64.36 151.16 12.94 24.83
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
0.00 0.00 0.16 0.22 0.23 0.19 0.18 0.13 0.11 0.01 0.14
Long-Term Debt to Equity
0.00 0.00 0.16 0.22 0.22 0.18 0.18 0.13 0.10 0.01 0.13
Financial Leverage
-0.24 -0.27 -0.04 -0.06 -0.07 -0.13 0.09 0.10 0.11 0.06 0.02
Leverage Ratio
1.71 1.67 1.88 1.95 1.89 1.78 1.90 2.00 1.97 1.85 1.83
Compound Leverage Factor
1.97 -2.64 1.59 1.70 3.21 3.06 1.78 1.78 4.76 1.40 1.54
Debt to Total Capital
0.00% 0.00% 14.05% 18.11% 18.40% 15.68% 15.51% 11.88% 9.62% 0.53% 12.21%
Short-Term Debt to Total Capital
0.00% 0.00% 0.34% 0.32% 0.32% 0.26% 0.16% 0.70% 0.72% 0.00% 0.59%
Long-Term Debt to Total Capital
0.00% 0.00% 13.71% 17.79% 18.09% 15.42% 15.36% 11.18% 8.90% 0.53% 11.62%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.72% 0.72% 0.59% 0.57% 0.56% 0.56% 0.54% 0.55% 0.54% 0.45% 0.46%
Common Equity to Total Capital
99.28% 99.28% 85.36% 81.32% 81.03% 83.76% 83.95% 87.58% 89.84% 99.01% 87.33%
Debt to EBITDA
0.00 0.00 2.96 2.21 1.49 1.26 1.29 1.34 1.21 0.08 -8.28
Net Debt to EBITDA
0.00 0.00 2.64 1.86 1.21 1.07 1.12 0.96 0.91 -0.39 -0.83
Long-Term Debt to EBITDA
0.00 0.00 2.89 2.17 1.47 1.23 1.28 1.26 1.12 0.08 -7.88
Debt to NOPAT
0.00 0.00 11.94 -4.86 12.72 6.52 5.56 -14.92 -1.24 0.25 -3.23
Net Debt to NOPAT
0.00 0.00 10.64 -4.08 10.34 5.56 4.79 -10.72 -0.93 -1.20 -0.32
Long-Term Debt to NOPAT
0.00 0.00 11.65 -4.78 12.50 6.41 5.50 -14.04 -1.15 0.25 -3.07
Altman Z-Score
5.36 5.47 4.60 4.35 3.36 3.30 4.08 4.11 4.74 4.41 5.15
Noncontrolling Interest Sharing Ratio
0.71% 0.69% 0.66% 0.66% 0.64% 0.56% 0.58% 0.57% 0.58% 0.00% 0.54%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
2.23 2.17 2.04 1.97 2.03 1.63 1.48 1.25 1.26 1.23 1.25
Quick Ratio
1.35 1.35 0.45 0.45 0.34 0.44 0.77 0.63 0.61 0.60 0.68
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
8.85 9.24 112 80 76 58 -17 12 22 43 39
Operating Cash Flow to CapEx
-1,569.86% 2,920.75% 8,051.41% 155.31% 5.63% 786.05% -945.43% 64.04% -113.33% 396.31% 527.77%
Free Cash Flow to Firm to Interest Expense
41.53 33.71 134.49 83.61 91.93 59.27 -21.79 50.70 58.29 119.25 79.98
Operating Cash Flow to Interest Expense
-20.78 39.55 13.73 2.17 0.07 4.81 -20.13 8.60 -15.59 22.42 42.99
Operating Cash Flow Less CapEx to Interest Expense
-22.11 38.19 13.55 0.77 -1.18 4.20 -22.26 -4.83 -29.34 16.76 34.85
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
1.98 1.92 2.54 2.43 1.49 1.54 1.65 2.00 2.43 1.85 2.74
Accounts Receivable Turnover
16.74 17.45 15.77 15.89 12.09 12.79 8.98 10.19 13.84 11.16 15.41
Inventory Turnover
11.94 12.50 18.91 16.88 9.90 10.90 12.07 13.76 16.80 14.49 22.08
Fixed Asset Turnover
12.32 11.49 11.89 0.00 6.73 0.00 6.08 0.00 9.06 0.00 0.00
Accounts Payable Turnover
105.76 85.81 71.60 71.56 47.33 68.43 44.63 42.79 66.69 70.68 105.42
Days Sales Outstanding (DSO)
21.81 20.91 23.14 22.97 30.18 28.54 40.65 35.80 26.37 32.69 23.69
Days Inventory Outstanding (DIO)
30.57 29.20 19.30 21.62 36.87 33.48 30.25 26.53 21.73 25.20 16.53
Days Payable Outstanding (DPO)
3.45 4.25 5.10 5.10 7.71 5.33 8.18 8.53 5.47 5.16 3.46
Cash Conversion Cycle (CCC)
48.92 45.85 37.34 39.49 59.34 56.69 62.72 53.81 42.63 52.73 36.76
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
151 142 154 160 156 160 254 234 234 218 229
Invested Capital Turnover
4.48 4.38 4.96 5.04 3.02 3.15 2.88 3.66 4.28 3.24 4.93
Increase / (Decrease) in Invested Capital
-5.11 -17 -100 -74 -78 -58 25 -11 -22 -40 -38
Enterprise Value (EV)
358 411 455 517 491 473 697 579 574 581 698
Market Capitalization
408 469 423 478 453 438 661 557 556 586 693
Book Value per Share
$11.29 $11.25 $11.45 $11.57 $11.32 $11.76 $12.24 $11.94 $12.15 $12.54 $12.66
Tangible Book Value per Share
$10.72 $10.68 $10.86 $10.98 $10.73 $11.17 $10.29 $9.96 $10.15 $10.52 $10.62
Total Capital
203 202 239 253 248 249 259 242 240 225 257
Total Debt
0.00 0.00 34 46 46 39 40 29 23 1.20 31
Total Long-Term Debt
0.00 0.00 33 45 45 38 40 27 21 1.20 30
Net Debt
-52 -59 30 38 37 33 35 21 17 -5.72 3.15
Capital Expenditures (CapEx)
0.28 0.37 0.14 1.35 1.03 0.60 1.63 3.28 5.19 2.03 3.95
Debt-free, Cash-free Net Working Capital (DFCFNWC)
39 28 121 126 120 49 47 26 28 21 28
Debt-free Net Working Capital (DFNWC)
87 85 123 130 125 52 49 31 30 24 32
Net Working Capital (NWC)
87 85 122 129 125 52 49 29 28 24 30
Net Nonoperating Expense (NNE)
-0.70 -8.15 13 0.62 4.10 8.39 1.39 5.42 2.37 6.15 -0.36
Net Nonoperating Obligations (NNO)
-52 -59 -51 -47 -46 -50 35 21 17 -5.72 3.15
Total Depreciation and Amortization (D&A)
1.94 1.93 2.04 2.08 4.56 4.47 4.36 4.29 4.17 4.12 4.07
Debt-free, Cash-free Net Working Capital to Revenue
5.65% 4.28% 12.00% 12.66% 20.35% 8.32% 6.80% 3.02% 2.64% 2.67% 2.30%
Debt-free Net Working Capital to Revenue
12.69% 12.91% 12.11% 13.09% 21.31% 8.80% 7.11% 3.50% 2.81% 3.08% 2.58%
Net Working Capital to Revenue
12.69% 12.91% 12.03% 13.01% 21.17% 8.69% 7.05% 3.30% 2.65% 3.08% 2.46%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
$0.25 ($0.01) ($0.04) $0.34 ($0.35) ($0.44) $0.37 ($0.23) ($0.17) ($0.18) $0.07
Adjusted Weighted Average Basic Shares Outstanding
17.84M 17.80M 17.80M 17.80M 17.80M 17.75M 17.76M 17.72M 17.67M 17.66M 17.67M
Adjusted Diluted Earnings per Share
$0.25 ($0.01) ($0.04) $0.34 ($0.35) ($0.44) $0.37 ($0.23) ($0.17) ($0.18) $0.07
Adjusted Weighted Average Diluted Shares Outstanding
17.90M 17.86M 17.84M 17.87M 17.80M 17.85M 17.86M 17.72M 17.67M 17.75M 17.77M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
17.84M 17.84M 17.80M 17.80M 17.80M 17.80M 17.76M 17.78M 17.74M 17.73M 17.73M
Normalized Net Operating Profit after Tax (NOPAT)
4.03 1.13 6.55 6.91 -1.89 1.80 7.15 1.75 1.01 2.86 1.14
Normalized NOPAT Margin
2.61% 0.66% 3.65% 3.75% -1.48% 1.27% 4.44% 1.10% 0.76% 0.00% 0.33%
Pre Tax Income Margin
3.13% 0.27% 2.51% 3.63% -1.57% -0.64% 7.24% 1.26% -0.48% 0.00% 0.75%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
19.70 -1.05 6.41 7.96 -1.43 -0.54 16.20 9.14 -0.70 -1.64 6.30
NOPAT to Interest Expense
17.53 -30.13 14.83 6.98 -2.62 0.48 10.58 5.96 -1.12 7.44 1.97
EBIT Less CapEx to Interest Expense
18.38 -2.41 6.24 6.56 -2.68 -1.15 14.07 -4.28 -14.46 -7.30 -1.85
NOPAT Less CapEx to Interest Expense
16.21 -31.48 14.66 5.58 -3.87 -0.13 8.45 -7.46 -14.88 1.78 -6.17
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
110.75% -871.19% -80.54% -519.56% -62.23% -130.95% -245.16% -77.08% -97.42% -307.94% -125.83%
Augmented Payout Ratio
110.75% -871.19% -80.54% -519.56% -62.23% -130.95% -245.16% -77.08% -97.42% -307.94% -125.83%

Frequently Asked Questions About Calavo Growers' Financials

When does Calavo Growers's fiscal year end?

According to the most recent income statement we have on file, Calavo Growers' financial year ends in October. Their financial year 2024 ended on October 31, 2024.

How has Calavo Growers' net income changed over the last 2 years?

Calavo Growers' net income appears to be on a downward trend, with a most recent value of -$1.02 million in 2024, falling from -$6.60 million in 2022. The previous period was -$7.97 million in 2023. View Calavo Growers' forecast to see where analysts expect Calavo Growers to go next.

What is Calavo Growers's operating income?
Calavo Growers's total operating income in 2024 was $16.72 million, based on the following breakdown:
  • Total Gross Profit: $67.80 million
  • Total Operating Expenses: $51.08 million
How has Calavo Growers revenue changed over the last 2 years?

Over the last 2 years, Calavo Growers' total revenue changed from $769.69 million in 2022 to $661.54 million in 2024, a change of -14.1%.

How much debt does Calavo Growers have?

Calavo Growers' total liabilities were at $99.34 million at the end of 2024, a 43.8% decrease from 2023, and a 38.8% decrease since 2022.

How much cash does Calavo Growers have?

In the past 2 years, Calavo Growers' cash and equivalents has ranged from $2.06 million in 2022 to $57.03 million in 2024, and is currently $57.03 million as of their latest financial filing in 2024.

How has Calavo Growers' book value per share changed over the last 2 years?

Over the last 2 years, Calavo Growers' book value per share changed from 12.54 in 2022 to 11.25 in 2024, a change of -10.3%.



This page (NASDAQ:CVGW) was last updated on 5/28/2025 by MarketBeat.com Staff
From Our Partners